A phase III trial comparing an anionic phospholipid-based (APP) cream and aloe vera-based gel in the prevention and treatment of radiation dermatitis

      Purpose/Objective: Radiation dermatitis is common among children and adults treated with radiation therapy (RT). Treatment interruptions occur in severe cases impacting a planned course of continuous RT. Radiation dermatitis is known to be exacerbated by pre-existing conditions, the administration of chemotherapy or therapeutic intent. No specific agent has been identified as superior in the prevention of this treatment-related effect. A phase III trial was conducted to compare a novel anionic phospholipid-based (APP) cream and an aloe vera-based gel in the prevention and treatment of radiation dermatitis using qualitative and quantitative measures in children treated with radiation therapy.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.